Square Pharmaceuticals Ltd

Square Pharmaceuticals Ltd

Square Pharma maintained an average of 18.4 percent annual profit growth over the last seven years/Photo: Courtesy

Square Pharmaceuticals’ annual profit grows by 19.38%

60% cash dividend recommended for 2020-21

Square to start drug production in Kenya by August

Square to start drug production in Kenya by August

Square Pharma investing Tk250cr to meet growing demand

Square Pharma investing Tk250cr to meet growing demand

Square Pharma sales up 12% amid pandemic

Square Pharma sales up 12% amid pandemic

Square Pharma to invest Tk350cr to expand business

Square Pharma to invest Tk350cr to expand business